Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B
- PMID: 175019
- PMCID: PMC420610
- DOI: 10.1128/iai.13.1.298-301.1976
Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B
Abstract
Treatment of bacterial lipopolysaccharides (endotoxins) isolated from Salmonella minnesota R595 or purified lipid A with the antibiotic polymyxin B has been demonstrated to abrogate the ability of these molecules to activate serum complement. The inhibition is a function of the ratio of polymyxin B to lipopolysaccharide.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
